Yu S - Search Results

1

Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study.

Zhou N, Hua Y, Ge Y, Wang Q, Wang C, He J, Zhao L, Yu S, Yan J, Zhao L, Li L, Bai C. Zhou N, et al. Among authors: yu s. Front Immunol. 2024 Dec 2;15:1482005. doi: 10.3389/fimmu.2024.1482005. eCollection 2024. Front Immunol. 2024. PMID: 39687611 Free PMC article. Clinical Trial.

2

Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma.

Zhou N, Tang H, Yu S, Lin Y, Wang Y, Wang Y. Zhou N, et al. Among authors: yu s. Front Immunol. 2022 Dec 6;13:1001414. doi: 10.3389/fimmu.2022.1001414. eCollection 2022. Front Immunol. 2022. PMID: 36561745 Free PMC article.

3

Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review.

Zhu Z, Zhou N, Yu S, Gao X, Cheng X, Wang Y, Bai C. Zhu Z, et al. Among authors: yu s. Onco Targets Ther. 2023 Nov 1;16:905-911. doi: 10.2147/OTT.S430273. eCollection 2023. Onco Targets Ther. 2023. PMID: 37933332 Free PMC article.

4

Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay.

Yu S, Shao H, Ban X, Zhang H, You Y, Zhou N, Mao X, Zhao H, Chen J, Lu Z. Yu S, et al. Front Oncol. 2019 Sep 4;9:831. doi: 10.3389/fonc.2019.00831. eCollection 2019. Front Oncol. 2019. PMID: 31552169 Free PMC article.

5

Alectinib relieves ischemic strokes caused by left atrial metastasis in a NSCLC patient with a novel SLC34A2-ALK (exon 1: exon 15) fusion.

Zhou N, Wu M, Yuan M, Wu H, Yu S, Gao X, Wang Y. Zhou N, et al. Among authors: yu s. Lung Cancer. 2023 Sep;183:107289. doi: 10.1016/j.lungcan.2023.107289. Epub 2023 Jul 1. Lung Cancer. 2023. PMID: 37542770

6

Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma.

Chen X, Ma H, Mo S, Yu S, Lu Z, Chen J. Chen X, et al. Among authors: yu s. Front Immunol. 2022 Oct 17;13:1027459. doi: 10.3389/fimmu.2022.1027459. eCollection 2022. Front Immunol. 2022. PMID: 36325339 Free PMC article.

7

Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.

Zong L, Zhang Q, Zhou Y, Kong Y, Yu S, Chen J, Zhang Y, Xiang Y. Zong L, et al. Among authors: yu s. J Immunol Res. 2020 Apr 3;2020:1283632. doi: 10.1155/2020/1283632. eCollection 2020. J Immunol Res. 2020. PMID: 32322590 Free PMC article.

8

Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma.

Chen X, Ma H, Mo S, Zhang Y, Lu Z, Yu S, Chen J. Chen X, et al. Among authors: yu s. Front Immunol. 2022 Jul 22;13:942154. doi: 10.3389/fimmu.2022.942154. eCollection 2022. Front Immunol. 2022. PMID: 35936015 Free PMC article.

9

The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.

Zong L, Zhang Q, Kong Y, Yang F, Zhou Y, Yu S, Wu M, Chen J, Zhang Y, Xiang Y. Zong L, et al. Among authors: yu s. Gynecol Oncol. 2020 Mar;156(3):676-681. doi: 10.1016/j.ygyno.2019.12.022. Epub 2019 Dec 24. Gynecol Oncol. 2020. PMID: 31882242

10

Expression of the immune checkpoint VISTA in breast cancer.

Zong L, Mo S, Yu S, Zhou Y, Zhang M, Chen J, Xiang Y. Zong L, et al. Among authors: yu s. Cancer Immunol Immunother. 2020 Aug;69(8):1437-1446. doi: 10.1007/s00262-020-02554-3. Epub 2020 Apr 7. Cancer Immunol Immunother. 2020. PMID: 32266446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,725 results

Search Page

Filters